More recent studies of exome sequencing performed on clear-cell ovarian cancer samples have provided definitive evidence that chromatin remodeling and PI3K are major drivers in clear cell carcinomas, with frequencies of ARID1A gene mutations of 60–65% and PIK3CA of 50–52% [129,130]. The gene discussed is ARID1A; the disease is ovarian clear cell cancer.